All In Biotech

Drug Trial Radar · NCT03201562

A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

Last checked: Nov 20, 2026Latest source record: Sep 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

58

Actual

Start

Apr 30, 2017

Primary completion

May 20, 2018

Study completion May 20, 2018

Sponsor

Lead sponsor
LENZ Therapeutics, IncAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 28, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 48 years, up to 64 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

To evaluate the safety and efficacy of PRX-100 compared with aceclidine alone and vehicle in the treatment of early to moderate presbyopia.

Conditions

  • Presbyopia

Interventions

  • Aceclidine+tropicamide combinationDrug

    Ophthalmic Solution

  • AceclidineDrug

    Ophthalmic Solution

  • VehicleDrug

    Ophthalmic Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects With at Least a 3 Line (15 Letter) Improvement in Near Visual Acuity in the Study EyeTime frame: 1 hour post-treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Andover Eye Associates

    Andover, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.